PGR and endometrial cancer: Furthermore high concentrations of MF were unable to block growth inhibition induced by supra-pharmacological doses of progesterone (i.e. concentrations higher than needed to saturate the cognate PR) in endometrial cancer cells carrying PR [9]; instead high doses of MF potentiated the growth retardation and induction of apoptosis triggered by high doses of progesterone [10].